<DOC>
	<DOCNO>NCT02221622</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability allopregnanolone , naturally occur brain steroid , mild cognitive impairment early Alzheimer 's disease participant . The primary goal determine maximally tolerate dose .</brief_summary>
	<brief_title>Allopregnanolone Mild Cognitive Impairment Due Alzheimer 's Disease Mild AD</brief_title>
	<detailed_description>1 ) Each dose group comprise 8 participant ( 6 randomize allopregnanolone ; 2 randomize placebo ) administer one dose allopregnanolone placebo per week 12 week . A high dose administer next group participant low dose show safe tolerable . 2 ) Pharmacokinetic analysis conduct blood sample take participant begin end trial . 3 ) The trial ass safety include via MRI brain imaging .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Pregnanolone</mesh_term>
	<criteria>Men postmenopausal woman 55 year age old Diagnosis MCI due AD mild AD MMSE &gt; 20 screen Capacity provide inform consent Residing community caregiver able accompany patient clinic visit No medical contraindication participation Willingness comply study procedure Use benzodiazepine , sedative/hypnotics , anticonvulsant , antipsychotic , drug might interact GABAA receptor complex Seizure disorder , history stroke , focal brain lesion , traumatic brain injury , substance abuse , malignancy Clinically significant laboratory ECG abnormality MRI indicative significant abnormality , include limited evidence cerebral contusion , encephalomalacia , aneurysms , vascular malformation , subdural hematoma , space occupy lesion Any condition would contraindicate MRI presence metallic object eye , skin , heart , body</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Alzheimer 's disease</keyword>
	<keyword>Mild Cognitive Impairment</keyword>
	<keyword>Dementia</keyword>
	<keyword>Regenerative therapeutic</keyword>
</DOC>